𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of Severe Myasthenia Gravis with Protein A Immunoadsorption and Cyclophosphamide

✍ Scribed by Flachenecker, Peter; Taleghani, Behrouz Mansouri; Gold, Ralf; Grossmann, Ralf; Wiebecke, Dieter; Toyka, Klaus Viktor

Book ID
122986398
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
55 KB
Volume
19
Category
Article
ISSN
0955-3886

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term treatment of myasthenia gravis
Long-term treatment of myasthenia gravis with immunoadsorption
✍ Martin Haas; Norbert Mayr; Josef Zeitlhofer; Andreas Goldammer; Kurt Derfler πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB

Acute treatment of myasthenic crisis with immunoadsorption (IA) or plasma exchange is well established. The efficiency of chronic apheresis therapy in myasthenia gravis (MG), however, and its efficacy in reducing concomitant potentially harmful immunosuppressive therapy, is unknown. We treated 13 pa

Use of intravenous pulsed cyclophosphami
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis
✍ Lucas Gustavo De Feo; Juan Schottlender; NΓ©stor A. Martelli; NΓ©stor A. Molfino πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 153 KB

## Abstract Twenty‐three myasthenia gravis (MG) subjects, mean (SD) age 41.6 years (14), showing poor disease control or steroid‐related side effects, received treatment for 12 months with intravenous cyclophosphamide (CP; __n__ = 12) or placebo (PL; __n__ = 11) in a randomized, double‐blind trial.